FibroBiologics (FBLG) Capital Expenditures (2023 - 2025)
FibroBiologics (FBLG) posted quarterly Capital Expenditures of $6000.0 for Q3 2025, down 45.45% year-over-year from $11000.0 in Q3 2024, and down 97.18% on a QoQ basis from $213000.0 in Q2 2025.
FibroBiologics (FBLG) Capital Expenditures (2023 - 2025) Analysis & Trends
FibroBiologics has reported Capital Expenditures for 3 years, with the latest figure at $6000.0 in Q3 2025.
- Capital Expenditures for Q3 2025 came in at $6000.0, down 45.45% year-over-year; the trailing twelve-month figure through Jun 2026 was $6000.0 (down 98.36% YoY), and the FY2025 annual result was $262000.0, up 42.39% from the prior year.
- Capital Expenditures retreated to $6000.0 in Q3 2025, from $213000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $413000.0 in Q3 2023 and troughed at $2000.0 in Q4 2023.
- A 3-year average of $85545.5 and a median of $43000.0 in 2025 frame the typical range for Capital Expenditures.
- The largest YoY upside for Capital Expenditures was 4850.0% in 2024 against a maximum downside of 97.34% in 2024.
- A 3-year view of Capital Expenditures shows it stood at $2000.0 in 2023, then soared by 4850.0% to $99000.0 in 2024, then slumped by 93.94% to $6000.0 in 2025.
- Per Business Quant data, the three most recent Capital Expenditures figures were $6000.0 in Q3 2025, $213000.0 in Q2 2025, and $43000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 34.68 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.26 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 251.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -73.57 Mn |
| 10 | FibroBiologics | 8.15 Mn | 8.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6,000.00 |
| Sep 30, 2025 | 6,000.00 |
| Jun 30, 2025 | 213,000.00 |
| Jun 30, 2025 | 213,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Mar 31, 2025 | 43,000.00 |
| Dec 31, 2024 | 99,000.00 |
| Dec 31, 2024 | 99,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Sep 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Jun 30, 2024 | 66,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Mar 31, 2024 | 8,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Dec 31, 2023 | 2,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Sep 30, 2023 | 413,000.00 |
| Jun 30, 2023 | 24,000.00 |
| Jun 30, 2023 | 24,000.00 |